Biomarin Pharmaceutical Inc (BMRN)
64.26
+0.81
(+1.28%)
USD |
NASDAQ |
Nov 22, 16:00
64.25
-0.01
(-0.02%)
After-Hours: 20:00
Biomarin Pharmaceutical Stock Buybacks (Quarterly)
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 50.00M |
| March 31, 2020 | |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | 0.00 |
| September 30, 2016 | -712.94M |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | -888.26M |
| December 31, 2014 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | -117.46M |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | -0.055M |
| June 30, 2012 | -235.44M |
| March 31, 2012 | |
| December 31, 2011 | 0.00 |
| September 30, 2011 | 11.58M |
| June 30, 2011 | -8.445M |
| March 31, 2011 | -3.133M |
| December 31, 2010 | 19.89M |
| September 30, 2010 | -6.722M |
| June 30, 2010 | -13.17M |
| March 31, 2010 | |
| December 31, 2009 | |
| September 30, 2009 | |
| June 30, 2009 | |
| March 31, 2009 | |
| December 31, 2008 | |
| September 30, 2008 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2019
50.00M
Maximum
Jun 2020
12.50M
Average
--
Median
Dec 2019
Stock Buybacks (Quarterly) Benchmarks
| Merck & Co Inc | 444.00M |
| Bristol-Myers Squibb Co | 0.00 |
| Pfizer Inc | -- |
| Biogen Inc | -- |
| Moderna Inc | -8.00M |